Use of zinc tranexamate in the treatment of diabetes
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 19, 2002
Grant Date -
Oct 18, 2001
app pub date -
Mar 7, 2001
filing date -
Mar 8, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A new use of a zinc tranexamate compound in the treatment of diabetes is disclosed. Oral administration of the compound adequately slows down absorption of glucose from digestive tracts by inhibiting .alpha.-glucosidase in vivo. The zinc tranexamate compound is also effective in the treatment of insulin-resistant type II diabetes.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully